Eli Lilly and Company's Fiscal Year is From January To December.
The item "FCFE-Dividend-Plus-Stock-Repurchases-Coverage" stands at 2.04 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of Eli Lilly and Company's third quarter, the item "FCFE Dividend Plus Stock Repurchases Coverage" stands at 2.04. This represents an increase of 86.56 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 970.91 percent compared to the value the year prior.
The 1 year change in percent is 970.91.
The 3 year change in percent is 220.71.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - FCFE Dividend Plus Stock Repurchases Coverage | 486,508,953,600.00 |
![]() | AbbVie Inc - FCFE Dividend Plus Stock Repurchases Coverage | 399,570,305,024.00 |
![]() | Roche Holding AG - FCFE Dividend Plus Stock Repurchases Coverage | 317,433,206,677.55 |
![]() | AstraZeneca PLC - FCFE Dividend Plus Stock Repurchases Coverage | 280,205,508,085.11 |
![]() | Novartis AG - FCFE Dividend Plus Stock Repurchases Coverage | 255,096,620,580.91 |